Search by Drug Name or NDC
NDC 70710-1667-01 Prochlorperazine Maleate 5 mg/1 Details
Prochlorperazine Maleate 5 mg/1
Prochlorperazine Maleate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is PROCHLORPERAZINE MALEATE.
MedlinePlus Drug Summary
Prochlorperazine suppositories and tablets are used to control severe nausea and vomiting. Prochlorperazine tablets are also used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Prochlorperazine tablets are also used on a short-term basis to treat anxiety that could not be controlled by other medications. Prochlorperazine should not be used to treat any condition in children who are younger than 2 years old or who weigh less than 20 pounds (about 9 kilograms). Prochlorperazine is in a class of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
Related Packages: 70710-1667-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Prochlorperazine
Product Information
| NDC | 70710-1667 |
|---|---|
| Product ID | 70710-1667_526a818f-9b98-4b47-9974-4c363151578e |
| Associated GPIs | |
| GCN Sequence Number | 003848 |
| GCN Sequence Number Description | prochlorperazine maleate TABLET 5 MG ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 14773 |
| HICL Sequence Number | 001629 |
| HICL Sequence Number Description | PROCHLORPERAZINE MALEATE |
| Brand/Generic | Generic |
| Proprietary Name | Prochlorperazine Maleate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Prochlorperazine Maleate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | PROCHLORPERAZINE MALEATE |
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA216495 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1667-01 (70710166701)
| NDC Package Code | 70710-1667-1 |
|---|---|
| Billing NDC | 70710166701 |
| Package | 100 TABLET in 1 BOTTLE (70710-1667-1) |
| Marketing Start Date | 2022-08-10 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.21652 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | PROCHLORPERAZINE 5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |